Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating EV-077 in type 2 diabetes assessing safety, tolerability, pharmacokinetics and pharmacodynamics; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EV-077

Snippet

Sponsor: Evolva SA | Conditions: Type 2 Diabetes | Phase 2 | Status: TERMINATED